Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00740025
NCT00740025CompletedNot Applicable

A Prospective Randomized Study of QD vs BID Dosing in ART

Virginia Center for Reproductive Medicine1 site in 1 country200 target enrollmentStarted: January 2006Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
Ongoing pregnancy
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a prospective randomized study evaluating dosing frequency of gonadotropin administration in ART cycles.

Detailed Description

Using once daily or bid dosing of gonadotropins in ART has been arbitrary with no studies showing whether splitting the medication dose improves ART parameters. This study was undertaken to provide an answer to this important question.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
21 Years to 39 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •women < 40 undergoing ART

Exclusion Criteria

  • •women > 40
  • •endometriomas
  • •severe cervical stenosis
  • •testicular sperm

Outcomes

Primary Outcomes

Ongoing pregnancy

Time Frame: 1 year

Secondary Outcomes

  • peak estradiol, number of follicles, number of oocytes, implantation rate, multiple pregnancy rate(1 year)

Investigators

Sponsor
Virginia Center for Reproductive Medicine
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Phase 2
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With DemodexDemodex Infestation of EyelidDemodectic BlepharitisBlepharitisMeibomian Gland Dysfunction
NCT06054217Tarsus Pharmaceuticals, Inc.36
Terminated
Phase 4
Type of Gonadotropin and Embryo Kinetics of DevelopmentInfertility
NCT02402192IVI Madrid201
Completed
Phase 2
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult WomenNocturia
NCT01684800Ferring Pharmaceuticals178
Completed
Phase 2
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult MenNocturia
NCT01694498Ferring Pharmaceuticals183
Completed
Phase 1
Intermittent Selumetinib for Uveal MelanomaUveal Melanoma
NCT02768766Shaheer A. Khan42